However, the sensitivity analyses showed when CAD deaths, which accounted for 11.5% percent of incident CAD cases, were removed from the analysis, the effect of FOXO3 genotype in moderating the effect of hypertension on incident CAD remained unchanged (Tables 4, row B and 5, row B). This evidence concerns the gene FOXO3 and coronary artery disorder.